MESA, ARIZONA, October 15, 2024 — DataBiologics, a leading platform for tracking and analyzing treatment outcomes in regenerative medicine, proudly announces the addition of three distinguished physicians to its Scientific/Medical Advisory Board: Dr. Walter Sussman, Dr. Ariana DeMers, and Dr. Don Buford. These accomplished experts bring a wealth of knowledge in orthopedics, sports medicine, and regenerative therapies, further advancing DataBiologics’ mission to drive data-driven treatment insights and improve patient outcomes.
Don Buford, MD, founder of Texas Orthobiologics, is a board-certified orthopedic surgeon renowned for his expertise in sports medicine and regenerative orthobiologic treatments. In addition to his clinical work, he has trained over 1,600 clinicians in musculoskeletal ultrasound and orthobiologics. He served as the 2021 President of the Interventional Orthobiologics Foundation (IOF) and currently serves on the boards of both IOF and the Arthroscopy Association of North America (AANA).
Ariana DeMers, DO, is an orthopedic surgeon at Restore Orthopedics & Sports Medicine, specializing in regenerative medicine and musculoskeletal health. She combines advanced orthobiologics with traditional orthopedic care, aiming to improve patient recovery without invasive surgery. She is a past President of the Interventional Orthobiologics Foundation (IOF) and also the founder of the Sierra Orthopedic Institute.
Walter Sussman, DO, is a dual board-certified physician in Physical Medicine & Rehabilitation and Sports Medicine. Founder of Boston Sports & Biologics, Dr. Sussman specializes in non-surgical alternatives for orthopedic conditions. He serves as an Assistant Clinical Professor at Tufts University School of Medicine and is a Board Director at the Interventional Orthobiologics Foundation (IOF).
They join an esteemed group of existing Scientific/Medical Advisory Board Members, including:
With the addition of these new members, DataBiologics continues to expand its expertise and commitment to advancing orthopedic and regenerative medicine through data collection and analysis. These advisors will guide the platform’s evolution, providing critical insights to ensure that clinicians and patients can benefit from evidence-based treatment decisions.
About DataBiologics
DataBiologics is an innovative platform for tracking and analyzing treatment outcomes in regenerative medicine and beyond. By partnering with leading healthcare providers and developing the latest technology, DataBiologics empowers physicians to improve patient outcomes through data-driven insights.